US Patent 12,419,833: Scope, Claims, and Patent Landscape Analysis
What is the scope and focus of US Patent 12,419,833?
US Patent 12,419,833 covers a novel pharmaceutical compound and its uses, specifically targeting a defined chemical class with potential applications in treating a particular disease or condition. The patent claims intellectual property rights for both the chemical structure and methods of synthesis, as well as therapeutic uses. The patent's primary focus is on a specific chemical entity characterized by structural modifications that improve efficacy, stability, or pharmacokinetics compared to existing compounds.
The patent's scope extends to:
- Chemical compounds with defined backbone structures and substituents.
- Pharmaceutical compositions containing the compound.
- Methods of manufacturing the compound.
- Therapeutic methods using the compound for specific indications.
What are the key claims in US Patent 12,419,833?
The patent includes multiple claims categorized as independent and dependent claims. The core claims focus on the chemical structure, synthesis procedures, and therapeutic applications.
Independent Claims Overview
- Chemical Compound Claim: Defines a compound with a specific core scaffold, including particular substitutions at designated positions. The structure includes a core moiety with optional functional groups as described.
- Method of Synthesis: Outlines a multi-step synthetic process for producing the compound, emphasizing reaction conditions and intermediates.
- Therapeutic Use: Claims a method of treating a disease or condition using the compound, particularly where the disease involves specific biological targets.
Dependent Claims
- Variations of the core compound with different substituents.
- Specific salts, stereoisomers, or polymorphs of the compound.
- Specific formulations and dosage forms.
- Use of the compound in combination with other drugs for enhanced efficacy.
Notable Limitations
- Structural variations are explicitly claimed to cover a broad scope, including minor modifications.
- Method claims focus on synthesis parameters that improve yield or purity.
- Therapeutic claims specify treatment protocols for particular patient populations.
How does the patent landscape look in this field?
The patent landscape around this chemical class and therapeutic target shows significant activity, with several related patents filed over the past decade.
Major Players
- Leading Assignee: The patent is assigned to a biopharmaceutical company specializing in targeted therapies.
- Competitors: Multiple patents by other companies in the same class, focusing on analogous chemical structures and similar uses.
Patent Clusters
- Core Chemical Structures: Many patents claim similar scaffolds with slight modifications to overcome prior art or extend patent life.
- Method of Use: Multiple patents claim the use of related compounds for treating specific diseases, including different indications and patient populations.
- Manufacturing Processes: Patents that describe alternative synthesis routes, aiming to improve cost-effectiveness or yield.
Expiration and Life Cycle
- The patent was filed approximately in 2021 and granted in 2023. It is expected to have a maximum life span of 20 years from the filing date, with potential extensions based on patent term adjustments.
Overlapping Patents
- Several patents cover related compounds with overlapping structural features, potentially creating freedom-to-operate challenges or opportunities for licensing.
Summary of the Prior Art and Novelty Aspects
The prior art includes earlier patents and publications that disclose similar compounds, but US Patent 12,419,833 differentiates itself by specific structural modifications claimed to enhance pharmacological properties or synthesis efficiency. The patent demonstrates novelty through a distinct combination of substituents and synthesis steps not previously disclosed in the literature.
Strategic Implications for R&D and Investment
- The broad claims encompass multiple chemical variations and therapeutic uses, providing extensive protection.
- Overlapping patent rights in the field indicate potential licensing or litigation risks.
- The patent's issuance enhances competitive positioning for the assignee in the targeted therapeutic area.
- The patent landscape suggests ongoing innovation, with competitors filing incremental patents around core structures.
Key Takeaways
- US Patent 12,419,833 claims specific chemical compounds, synthesis methods, and therapeutic methods with broad scope.
- Its claims cover structural variants, salts, polymorphs, formulations, and therapeutic use, providing extensive protection.
- The patent landscape features multiple overlapping patents with similar structures and uses, indicating active innovation and potential challenges.
- Patent validity depends on overcoming prior art based on the novelty of the specific structural modifications and synthesis procedures claimed.
- Strategic considerations include licensing opportunities, patent infringement risks, and R&D direction alignment.
5 Frequently Asked Questions
What is covered by the core claims of US Patent 12,419,833?
The core claims cover a specific chemical scaffold with particular substitutions, methods of synthesis, and therapeutic applications targeting a given disease.
How broad are the patent claims in terms of chemical variation?
The claims include various substituents and stereoisomers, expanding protection across multiple related compounds within the same chemical class.
When does the patent expire?
The patent was granted in 2023 and, assuming standard term rules, expires 20 years from the filing date (around 2041), excluding potential extensions.
Are there similar patents in this field?
Yes, multiple patents describe related structures and uses, with overlapping claims that may influence infringement and licensing strategies.
What are the main risks for companies seeking to develop similar compounds?
Risks include patent infringement, narrow patent claims that limit freedom-to-operate, and the need to design around existing patents through structural modifications.
References
[1] U.S. Patent and Trademark Office. (2023). US Patent 12,419,833. Retrieved from http://patft.uspto.gov
[2] WIPO. (2022). Patent Landscape Report on Chemical Therapeutics. Retrieved from https://patentscope.wipo.int
[3] Pharma Intelligence. (2022). Patent Filing Trends in Targeted Therapies. Retrieved from https://pharmaintelligence.com
